echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > In 2022, small and medium-sized pharmacies will still be eliminated or acquired at an accelerated pace

    In 2022, small and medium-sized pharmacies will still be eliminated or acquired at an accelerated pace

    • Last Update: 2022-01-22
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    In recent years, "large and small chain reorganization and mergers and acquisitions" have been staged in the pharmacy industry
    .
    For example, in the past 2021, the "big-handed" mergers and acquisitions of leading chain chains have continued one after another.
    Whether it was the common people, Yixintang, and Yifeng who were listed earlier, or Dashenlin, Jianzhijia, and Shuyu commoners who entered the capital market.
    All obviously regard mergers and acquisitions as an important measure for the company to expand its territory
    .
    According to incomplete statistics, as of the third quarter of 2021, the number of stores in the four major listed chains, Yixintang, Dashenlin, Common People, and Yifeng Pharmacy, has exceeded 7,000
    .
    Among them, the number of Yixintang and ordinary people's stores has reached more than 8,000
    .
    In addition, data shows that from 2011 to the first half of 2021, the number of pharmacies in China increased from 424,000 to 579,000, an increase of 36.
    56%; the number of chain stores increased from 147,000 to 329,600, An increase of 124.
    01%, the chain rate increased from 34.
    67% to 56.
    93%
    .
    The analysis believes that behind the continuous expansion of the head chain and the continuous increase of the pharmacy chain rate, it is actually the result that the industry competition is becoming increasingly fierce, and the small and medium-sized enterprises are facing the competitive pressure from the giants and are accelerating their withdrawal
    .
    It is understood that in recent years, with the impact of drug price cuts and volume purchases, the passenger flow and profits of the pharmacy industry have been declining, and the competition has become increasingly fierce
    .
    Therefore, under the background that the pharmacy industry has entered the "stock competition", in order to further expand the head chain, it has become a general trend to acquire other pharmacies
    .
    It is worth mentioning that the industry expects that in the future, chain pharmacies will continue to intensify mergers and acquisitions to further increase market share, and the industry market concentration will also accelerate
    .
    This conclusion is mainly due to the fact that on October 28, 2021, the Ministry of Commerce issued the "Guiding Opinions on Promoting the High-quality Development of the Pharmaceutical Circulation Industry during the "14th Five-Year Plan" Period", proposing requirements that will increase the concentration of the industry
    .
    Among them, the opinions clearly stated that by 2025, 5-10 specialized and diversified pharmaceutical retail chain enterprises with a value of over 50 billion yuan should be cultivated.
    The annual sales of the top 100 pharmaceutical retail enterprises should account for more than 65% of the total pharmaceutical retail market.
    The linkage rate is close to 70%
    .
    In this regard, the industry generally believes that with the help of this policy, the competition in the pharmaceutical retail market will become more intense in the future, the trend of expansion of large chain pharmacies will continue to accelerate, and more small and medium-sized pharmacies in the industry will also be accelerated.
    or mergers
    .
    In fact, according to the author's understanding, at the beginning of this year, a number of small and medium-sized pharmacies have quietly withdrawn
    .
    For example, on January 4, the website of the Haikou Market Supervision and Administration Bureau released an announcement on the cancellation of the "Drug Business License" of 38 pharmaceutical retail enterprises including the Penghui Plaza Branch of Hainan Qizhengtang Pharmaceutical Chain Operation Co.
    ,
    Ltd.
    In addition, on January 7, the Liaoyang Municipal Bureau of Supervision also issued an announcement stating that in accordance with the relevant provisions of the Drug Administration Law and the Measures for the Administration of Pharmaceutical Business Licenses, Liaoyang Tianzheng Pharmaceutical Co.
    , Ltd.
    Tianshui Chunguang Store and Liaoyang Tianzheng Pharmaceutical Co.
    , Ltd.
    The "Drug Business License" of Lingchun Tong Pharmacy shall be cancelled
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.